Adicet Bio, Inc. (ACET)
8.27
+0.12
(+1.47%)
USD |
NASDAQ |
Jun 24, 16:00
8.27
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 96.01% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00% |
| June 30, 2020 | -0.46% |
| March 31, 2020 | -1.70% |
| December 31, 2019 | -1.78% |
| September 30, 2019 | 0.48% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.75% |
| Alnylam Pharmaceuticals, Inc. | 81.91% |
| Anika Therapeutics, Inc. | 64.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 72.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.38% |
| Return on Assets | -63.54% |
| Return on Invested Capital | -69.85% |
| Return on Net Operating Assets | -333.9% |